- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00762437
Non-Invasive Cooling of Fat Cells
June 16, 2011 updated by: Zeltiq Aesthetics
The purpose of this study is to evaluate a non-invasive cooling device to determine if cold exposure will consistently result in a reduction of subcutaneous fat.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
240
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Sacramento, California, United States
- Investigational Site
-
San Diego, California, United States
- Investigational Site
-
-
District of Columbia
-
Washington, District of Columbia, United States
- Investigational Site
-
-
Florida
-
Miami, Florida, United States
- Investigational Site
-
-
Illinois
-
Chicago, Illinois, United States
- Investigational Site
-
-
Maryland
-
Baltimore, Maryland, United States
- Investigational Site
-
-
Massachusetts
-
Boston, Massachusetts, United States
- Investigational Site
-
-
Minnesota
-
Minneapolis, Minnesota, United States
- Investigational Site
-
-
New Jersey
-
Hackensack, New Jersey, United States
- Investigational Site
-
-
New York
-
New York, New York, United States
- Investigational Site
-
-
Texas
-
Dallas, Texas, United States
- Investigational Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female subjects > 18 years of age.
- Subject has clearly visible fat on an area of the body appropriate for treatment with the non-invasive Zeltiq cooling device such as the flanks, thighs, abdomen or back.
- Subject has not had weight change fluctuations exceeding 10 pounds in the preceding month and plans to maintain their weight to within ±10 pounds over the next 6 months.
- Subject has read and signed a written informed consent form.
Exclusion Criteria:
- Subject has had liposuction, or another surgical procedure(s) or mesotherapy in area of intended treatment within the past 2 years.
- Subject has a known history of subcutaneous injections into the area of intended treatment (e.g., cortisone) within the past 6 months.
- Subject has a known history of cryoglobulinemia, cold urticaria, or paroxysmal cold hemoglobinuria.
- Subject has used diet pills within the past 6 months.
- Subject is unable or unwilling to comply with the study requirements.
- Subject has any dermatological conditions or scars within the location of the test sites that may interfere with the treatment or evaluation.
- Subject is currently enrolled in a clinical study of any other unapproved investigational drug or device.
- Patient is pregnant or intending to become pregnant in the next 9 months.
- Patient is lactating or has been lactating in the past 9 months.
- Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect response or participation in this clinical study, or would pose an unacceptable risk to the subject.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: 1
|
Noninvasive cooling is applied to the treatment area with a defined cooling rate and duration.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Visible improvement in treated area
Time Frame: 4 months
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Subject satisfaction
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (ACTUAL)
June 1, 2011
Study Completion (ACTUAL)
June 1, 2011
Study Registration Dates
First Submitted
September 27, 2008
First Submitted That Met QC Criteria
September 29, 2008
First Posted (ESTIMATE)
September 30, 2008
Study Record Updates
Last Update Posted (ESTIMATE)
June 20, 2011
Last Update Submitted That Met QC Criteria
June 16, 2011
Last Verified
May 1, 2009
More Information
Terms related to this study
Other Study ID Numbers
- ZA07005
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Reduction of Unwanted Fat
-
Syneron MedicalUnknownUnwanted Thigh FatUnited States
-
Syneron MedicalUnknown
-
Syneron MedicalUnknown
-
Syneron MedicalSuspendedUnwanted Flanks Fat
-
Zeltiq AestheticsCompleted
-
Cutera Inc.Terminated
-
Goldman, Butterwick, Fitzpatrick and GroffAllerganCompletedFat ReductionUnited States
-
University of BaghdadEman Hammad HafithCompleted
-
AllerganCompletedNon-invasive Fat ReductionAustralia, Canada, Singapore, United Kingdom
-
AllerganCompletedNon-invasive Fat ReductionUnited States, France, Singapore, Sweden, Germany
Clinical Trials on Zeltiq Dermal Cooling Device
-
R2 DermatologyRecruitingSkin LesionUnited States
-
R2 DermatologyCompleted
-
R2 DermatologyCompleted
-
R2 DermatologyCompleted
-
R2 DermatologyCompleted
-
R2 DermatologyCompleted
-
Riverchase DermatologyAllerganUnknownSubcutaneous FatUnited States
-
Massachusetts General HospitalCompletedAdiposityUnited States
-
Massachusetts General HospitalActive, not recruiting